ResMed Aktie
WKN DE: 895878 / ISIN: US7611521078
03.08.2023 23:23:53
|
Resmed Inc Q4 Profit Increases, but misses estimates
(RTTNews) - Resmed Inc (RMD) reported earnings for its fourth quarter that increased from the same period last year but missed the Street estimates.
The company's bottom line totaled $229.66 million, or $1.56 per share. This compares with $195.06 million, or $1.33 per share, in last year's fourth quarter.
Excluding items, Resmed Inc reported adjusted earnings of $235.49 million or $1.60 per share for the period.
Analysts on average had expected the company to earn $1.69 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 22.4% to $1.12 billion from $914.74 million last year.
Resmed Inc earnings at a glance (GAAP) :
-Earnings (Q4): $229.66 Mln. vs. $195.06 Mln. last year. -EPS (Q4): $1.56 vs. $1.33 last year. -Analyst Estimate: $1.69 -Revenue (Q4): $1.12 Bln vs. $914.74 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ResMed Inc.mehr Nachrichten
Analysen zu ResMed Inc.mehr Analysen
Aktien in diesem Artikel
ResMed Inc. | 216,30 | -0,60% |
|